Details for Patent: 5,716,942
✉ Email this page to a colleague
Summary for Patent: 5,716,942
Title: | Treatment of migraine with morpholine tachykinin receptor antagonists |
Abstract: | Substituted heterocycles of the general structural formula: ##STR1## are tachykinin receptor antagonists useful in the treatment of inflammatory diseases, pain or migraine, asthma, emesis and nausea. |
Inventor(s): | Dorn; Conrad P. (Plainfield, NJ), MacCoss; Malcolm (Freehold, NJ), Hale; Jeffrey J. (Westfield, NJ), Mills; Sander G. (Woodbridge, NJ) |
Assignee: | Merck & Co., Inc. (Rahway, NJ) |
Application Number: | 08/450,198 |
Patent Claim Types: see list of patent claims | Use; |
Drugs Protected by US Patent 5,716,942
Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Patented / Exclusive Use | Submissiondate |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
>Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Patented / Exclusive Use | >Submissiondate |
International Family Members for US Patent 5,716,942
Country | Patent Number | Estimated Expiration | Supplementary Protection Certificate | SPC Country | SPC Expiration |
---|---|---|---|---|---|
European Patent Office | 0748320 | ⤷ Sign Up | 08C0019 | France | ⤷ Sign Up |
European Patent Office | 0748320 | ⤷ Sign Up | SPC/GB08/021 | United Kingdom | ⤷ Sign Up |
Austria | 227722 | ⤷ Sign Up | |||
Australia | 1975095 | ⤷ Sign Up | |||
Australia | 700611 | ⤷ Sign Up | |||
>Country | >Patent Number | >Estimated Expiration | >Supplementary Protection Certificate | >SPC Country | >SPC Expiration |